Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Adv Healthc Mater. 2023 Feb 3;12(13):e2202729. doi: 10.1002/adhm.202202729

Figure 6.

Figure 6.

Protective efficacy of oriented HA constructs. a) Weight loss of mice immunized with either VLP-HARegular, VLP-HAInverted, or VLP and subsequently infected with cH6/1N5 virus at four different doses (101, 102, 103, or 104 pfu/mouse; mean ± SEM; n=3). b) Survival of mice immunized with either VLP-HARegular, VLP-HAInverted, or VLP and subsequently infected with cH6/1N5 virus at four different doses (101, 102, 103, or 104 pfu/mouse; n=3).